EP Patent

EP4358747A1 — Oral product tablet and method of manufacture

Assigned to Nicoventures Trading Ltd · Expires 2024-05-01 · 2y expired

What this patent protects

The disclosure provides products configured for oral use, and methods of making the products. The products include a plurality of granules, the granules including at least one filler; at least one sugar alcohol; a cellulose ether, polyvinylpyrrolidone, or a combination thereof; a…

USPTO Abstract

The disclosure provides products configured for oral use, and methods of making the products. The products include a plurality of granules, the granules including at least one filler; at least one sugar alcohol; a cellulose ether, polyvinylpyrrolidone, or a combination thereof; and at least one active ingredient, at least one flavorant, or a combination thereof. The products may be in a granular form, or in the form of a tablet or pellet.

Drugs covered by this patent

Patent Metadata

Patent number
EP4358747A1
Jurisdiction
EP
Classification
—
Expires
2024-05-01
Drug substance claim
No
Drug product claim
No
Assignee
Nicoventures Trading Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.